Eris Lifesciences Ltd.
Snapshot View

628.45 +2.15 ▲0.3%

07 February 2023, 04:01:00 PM
Volume: 424

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.eris.co.in
Market Cap 8,567.42 Cr.
Enterprise Value(EV) 8,692.27 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 29.20 Trailing Twelve Months Ending 2022-12
Price-Earning Ratio (PE) 21.53 Trailing Twelve Months Ending 2022-12
Industry PE 32.80 Trailing Twelve Months Ending 2022-12
Book Value / Share 156.42 Trailing Twelve Months Ending 2022-12
Price to Book Value 4.02 Calculated using Price: 628.45
Dividend Yield 0.95 Period Ending 2022-03
No. of Shares Subscribed 13.60 Cr. 135,990,717 Shares
FaceValue 1
Company Profile
The company develops, manufactures and commercializes branded pharmaceutical products in select therapeutic areas within the chronic and acute categories of the IPM, such as: cardiovascular; anti-diabetics; vitamins; gastroenterology; and anti-infectives. Its focus has been on developing products in the chronic and acute category which are linked to lifestyle related disorders.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+0.34%
1 Week
+2.91%
1 Month
-3.01%
3 Month
-12.55%
6 Month
-9.12%
1 Year
-10.81%
2 Year
+8.53%
5 Year
-17.88%
10 Year
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 50.12 40.30 47.68 56.90 41.30 28.96 24.28 24.78 23.33
Return on Capital Employed (%) 68.93 49.25 54.56 62.56 35.76 26.54 25.44 27.60 25.29
Return on Assets (%) 32.09 28.59 36.17 43.89 27.31 20.02 20.33 22.62 21.27

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 177 266 300 567 861 1,151 1,296 1,576 1,908 2,027
Non Curr. Liab. 18 19 20 12 248 -66 -80 -109 -79 183
Curr. Liab. 71 65 69 129 294 377 220 235 283 360
Minority Int. 4 4 3 24 25 18 0 30
Equity & Liab. 270 354 392 732 1,428 1,481 1,437 1,703 2,113 2,600
Non Curr. Assets 115 191 169 463 1,061 827 902 1,167 1,402 1,984
Curr. Assets 155 163 222 270 367 653 535 536 711 615
Misc. Exp. not W/O
Total Assets 270 354 392 732 1,428 1,481 1,437 1,703 2,113 2,600

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-12 Rs. Cr. TTM
Net Sales 509 546 597 750 856 982 1,074 1,212 1,347 1,588
Other Income 4 3 3 25 26 32 16 9 26 18
Total Income 513 549 600 775 882 1,014 1,090 1,221 1,373 1,607
Total Expenditure -410 -424 -425 -480 -533 -637 -706 -781 -862 -1,074
PBIDT 103 125 175 294 349 377 384 439 511 533
Interest 0 0 0 -1 -11 -23 -2 -2 -4 -19
Depreciation -5 -16 -20 -23 -26 -36 -50 -43 -65 -100
Taxation -27 -20 -20 -24 -17 -26 -35 -39 -36 -21
Exceptional Items
PAT 71 89 135 247 295 291 297 355 406 393
Minority Interest 0 0 -1 0 -1 0 0 0 4
Share Associate
Other Related Items
Consolidated Net Profit 71 89 134 247 294 291 297 355 406 397
Adjusted EPS 5,130 6,466 9,679 18 21 21 22 26 30 29

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 38 90 90 131 200 235 223 271 375 378
Cash Fr. Inv. -36 -83 -92 -44 -184 -590 -5 123 -323 -320
Cash Fr. Finan. -3 -2 0 -84 -24 363 -221 -335 -82 -45
Net Change -1 5 -2 4 -8 8 -3 60 -30 14
Cash & Cash Eqvt 2 7 5 9 2 11 8 67 37 51

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 54.23 54.13 52.69 52.68 52.66 52.66 52.30 52.29 52.70
Public 45.77 45.87 47.31 47.32 47.34 47.34 47.70 47.71 47.30
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Mon, 23 Jan 2023
INTIMATION UNDER REGULATION 30 AND OTHER APPLICABLE REGULATIONS OF SECURITIES AND EXCHANGE BOARD OF INDIA (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATIONS 2015
Dear Sir/Madam We would like to inform that the Company has given a corporate guarantee in favour of Eris Oaknet Healthcare Private Limited (EOHPL) a Wholly Owned Subsidiary for securing the Credit facility(ies) that it availed from HDFC Bank.Further in accordance requirement of regulations 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 read with Para B (11) of Part A to the Schedule III and SEBI Circular CIR/CFD/CMD/4/2015 dated September 09 2015 details attached herewith may please be taken on record.The details of the same will also be uploaded on the website of the Company.
Mon, 23 Jan 2023
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Dear Sir/Madam This is to inform that the transcript of the Analyst and Investor call which was held after the announcement of financial results for the quarter ended 31st December 2022 is available on our website URL https://eris.co.in/financials/(File name: Transcript of the Analyst and Investor Conference Call Q3FY23).
Thu, 19 Jan 2023
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
INTIMATION OF SCHEDULE OF ANALYST / INSTITUTIONAL INVESTOR MEETING

Technical Scans View Details >>

Tue, 07 Feb 2023
Closing Above Previous High Closing Above Previous High
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
High Decrease in 3 Months High Decrease in 3 Months
Closing Near 20 SMA Closing Near 20 SMA
MFI Below 20 MFI Below 20

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 241,289.12 1,005.65 -1.7%
Cipla Ltd. 83,256.90 1,031.50 +0.2%
Dr. Reddy's Laboratories Ltd. 73,968.14 4,441.90 +2.1%
Divi's Laboratories Ltd. 72,982.62 2,749.20 -1.0%
Apollo Hospitals Enterprise Ltd. 62,135.10 4,321.40 +0.1%
Torrent Pharmaceuticals Ltd. 51,898.92 1,533.45 -0.4%
Zydus Lifesciences Ltd. 48,525.07 479.40 +2.0%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 57.29 1,005.65 -1.7%
Cipla Ltd. Consolidated 2022-12 31.56 1,031.50 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 20.30 4,441.90 +2.1%
Divi's Laboratories Ltd. Consolidated 2022-12 30.45 2,749.20 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 74.00 4,321.40 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 62.45 1,533.45 -0.4%
Zydus Lifesciences Ltd. Consolidated 2022-12 23.54 479.40 +2.0%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.36 1,005.65 -1.7%
Cipla Ltd. Consolidated 2022-12 3.67 1,031.50 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.36 4,441.90 +2.1%
Divi's Laboratories Ltd. Consolidated 2022-12 5.87 2,749.20 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.38 4,321.40 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.14 1,533.45 -0.4%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.81 479.40 +2.0%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,005.65 -1.7%
Cipla Ltd. Consolidated 2022-03 0.04 1,031.50 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,441.90 +2.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,749.20 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,321.40 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,533.45 -0.4%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 479.40 +2.0%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,005.65 -1.7%
Cipla Ltd. Consolidated 2022-03 13.10 1,031.50 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,441.90 +2.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,749.20 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,321.40 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,533.45 -0.4%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 479.40 +2.0%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,005.65 -1.7%
Cipla Ltd. Consolidated 2022-03 13.10 1,031.50 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,441.90 +2.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,749.20 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,321.40 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,533.45 -0.4%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 479.40 +2.0%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,005.65 -1.7%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,031.50 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,441.90 +2.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,749.20 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,321.40 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,533.45 -0.4%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 479.40 +2.0%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,005.65 -1.7%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,031.50 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,441.90 +2.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,749.20 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,321.40 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,533.45 -0.4%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 479.40 +2.0%

FAQ's On Eris Lifesciences Ltd.

What is Eris Lifesciences share price?

Can I buy Eris Lifesciences shares now?

What is the Dividend Yield of Eris Lifesciences?

What is the Market Cap of Eris Lifesciences?

What are the key metrics to analyse Eris Lifesciences?

What is the 52 Week High and Low of Eris Lifesciences?

What is the trend of Eris Lifesciences share price?